At what point in the natural history of a cancer do you recommend that NGS-CGP with a hybrid capture-based platform like FoundationOne be performed?

At what point in the natural history of a cancer do you recommend that NGS-CGP with a hybrid capture-based platform like FoundationOne be performed?

At what point in the natural history of a cancer, in the individual patient, do you recommend that NGS-CGP with a hybrid capture-based platform like FoundationOne be performed? And what do you do with this information at each point in time?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Janice Tsang, MBBS, MRCP(UK), FRCP (Lond.)

Janice Tsang, MBBS, MRCP(UK), FRCP (Lond.)

Specialist in Medical Oncology
Hon. Clinical Assistant Professor
Li Ka Sing Faculty of Medicine
The University of Hong Kong